We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.04B
AUM Growth
+$154M
Cap. Flow
-$59.7M
Cap. Flow %
-2.92%
Top 10 Hldgs %
35.2%
Holding
397
New
70
Increased
71
Reduced
131
Closed
34

Top Buys

Rank Stock Value
1
UPS icon
United Parcel Service
UPS
+$27.2M
2
COST icon
Costco
COST
+$26.4M
3
KLAC icon
KLA
KLAC
+$25M
4
IQV icon
IQVIA
IQV
+$23.8M
5
USB icon
US Bancorp
USB
+$23.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$42.7M
2
PG icon
Procter & Gamble
PG
+$33.7M
3
LLY icon
Eli Lilly
LLY
+$32.3M
4
COHR icon
Coherent
COHR
+$22.3M
5
ABT icon
Abbott
ABT
+$21.1M

Sector Composition

Rank Sector Weight
1 Technology 31.29%
2 Consumer Discretionary 14.43%
3 Financials 12.78%
4 Healthcare 12.63%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRWD icon
351
Ironwood Pharmaceuticals
IRWD
$669M
$3K ﹤0.01%
230
PTCT icon
352
PTC Therapeutics
PTCT
$6.23B
$3K ﹤0.01%
70
ALLO icon
353
Allogene Therapeutics
ALLO
$725M
$2K ﹤0.01%
60
KYNB
354
Kyntra Bio
KYNB
$28.2M
$2K ﹤0.01%
3
HRTX icon
355
Heron Therapeutics
HRTX
$63.4M
$2K ﹤0.01%
120
INO icon
356
Inovio Pharmaceuticals
INO
$76.1M
$2K ﹤0.01%
15
RGNX icon
357
Regenxbio
RGNX
$688M
$2K ﹤0.01%
40
XNCR icon
358
Xencor
XNCR
$1.6B
$2K ﹤0.01%
60
ICPT
359
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
30
CCXI
360
DELISTED
ChemoCentryx, Inc.
CCXI
$1K ﹤0.01%
60
ABT icon
361
Abbott
ABT
$188B
-175,909
Closed -$21.1M
ADUS icon
362
Addus HomeCare
ADUS
$2.23B
-6,080
Closed -$636K
AHCO icon
363
AdaptHealth
AHCO
$696M
-17,762
Closed -$653K
BBY icon
364
Best Buy
BBY
$17.4B
-5,310
Closed -$610K
BNY
365
Bank of New York Mellon
BNY
$108B
-634
Closed -$30K
BOKF icon
366
BOK Financial
BOKF
$8.7B
-251
Closed -$22K
CHTR icon
367
Charter Communications
CHTR
$18.3B
-1,105
Closed -$682K
CLX icon
368
Clorox
CLX
$13B
-30
Closed -$6K
COHR icon
369
Coherent
COHR
$63.6B
-325,555
Closed -$22.3M
DG icon
370
Dollar General
DG
$27B
-600
Closed -$122K
DVA icon
371
DaVita
DVA
$11.7B
-2,310
Closed -$249K
EBAY icon
372
eBay
EBAY
$47.9B
-193,547
Closed -$11.9M
FHI icon
373
Federated Hermes
FHI
$4.71B
-660
Closed -$21K
HOLX
374
DELISTED
Hologic
HOLX
-574,290
Closed -$42.7M
IRBT
375
DELISTED
iRobot
IRBT
-120
Closed -$15K

Similar funds

Smith Group Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Smith Group Asset Management held 397 positions worth $2.04B, up 8.2% from $1.89B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Smith Group Asset Management's Q2 2021 filing shows 70 new, 71 increased, 131 reduced and 34 closed positions. Its largest new stake was KLA: 780,720 shares worth $25.3M. The largest sale was Hologic, an estimated $42.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Smith Group Asset Management's largest Q2 2021 buy was KLA: 780,720 shares worth $25.3M.
  • Smith Group Asset Management added most to United Parcel Service in Q2 2021, an estimated $27.2M increase.
  • Smith Group Asset Management's biggest Q2 2021 reduction was Procter & Gamble, cutting an estimated $33.7M.
  • Smith Group Asset Management fully exited Hologic in Q2 2021, selling an estimated $42.7M.
  • Smith Group Asset Management's ten largest holdings make up 35% of its $2.04B portfolio in Q2 2021.
  • Smith Group Asset Management opened 70 new positions and closed 34 in Q2 2021.
  • Smith Group Asset Management's portfolio value rose 8.2% quarter-over-quarter to $2.04B.

Based on Smith Group Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.